Rallybio Corp Quarterly Operating Income (Loss) in USD from Q2 2020 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Rallybio Corp quarterly/annual Operating Income (Loss) history and growth rate from Q2 2020 to Q2 2024.
  • Rallybio Corp Operating Income (Loss) for the quarter ending June 30, 2024 was -$17M, a 15.2% increase year-over-year.
  • Rallybio Corp Operating Income (Loss) for the twelve months ending June 30, 2024 was -$77.3M, a 3.88% decline year-over-year.
  • Rallybio Corp annual Operating Income (Loss) for 2023 was -$78.9M, a 16.3% decline from 2022.
  • Rallybio Corp annual Operating Income (Loss) for 2022 was -$67.9M, a 48.7% decline from 2021.
  • Rallybio Corp annual Operating Income (Loss) for 2021 was -$45.6M, a 80.4% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 -$77.3M -$17M +$3.05M +15.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$80.3M -$19.8M -$1.41M -7.69% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$78.9M -$21.1M -$4.02M -23.5% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-12
Q3 2023 -$74.9M -$19.4M -$503K -2.67% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-09
Q2 2023 -$74.4M -$20.1M -$2.47M -14% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$71.9M -$18.4M -$4.06M -28.3% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$67.9M -$17.1M -$4.78M -38.8% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-12
Q3 2022 -$63.1M -$18.9M -$8.88M -89% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$54.2M -$17.6M -$7.09M -67.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-08
Q1 2022 -$47.1M -$14.3M -$1.49M -11.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-09
Q4 2021 -$45.6M -$12.3M Oct 1, 2021 Dec 31, 2021 10-K 2023-03-06
Q3 2021 -$9.98M -$3.27M -48.7% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-07
Q2 2021 -$10.5M -$5.87M -126% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-08
Q1 2021 -$12.8M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-10
Q3 2020 -$6.71M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 -$4.66M Apr 1, 2020 Jun 30, 2020 10-Q 2021-09-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.